Newton, Massachusetts – March 2015.

NeuroHealing Pharmaceuticals, a private, clinical stage company developing innovative drug treatments for specialty indications based on repositioning neurologically active compounds, announces the publication of a comprehensive scientific review article describing the rationale and development of NH004 for the treatment of patients with sialorrhea.  The review article is entitled “Design and Development of a Novel Supportive Care Product for the Treatment of Sialorrhea in Parkinson’s Disease” (Current Topics in Medicinal Chemistry, 15:10, 939-954, 2015).

About the author